Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > Likelihood of ACB-CMED merger
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Dowtownon Jan 11, 2018 12:01pm
103 Views
Post# 27333615

RE:RE:RE:RE:RE:Likelihood of ACB-CMED merger

RE:RE:RE:RE:RE:Likelihood of ACB-CMED mergerAccording to Zettl It's a $50 stock but all that damn monopoly money from Aurora is holding him back. I'm not a lawyer but I feel it is illegal to just spew out speculative numbers when you are a aren't even licensed to give financial advice.
cnixon15 wrote: Quarterly Sales Canopy Growth $13.9m (usd) MedReleaf $7.8m (usd) Aurora Cannabis $6.5m (usd) CannTrust $4.89m (usd) Aphria $4.87m (usd) Isodiol International $4m (usd) MPX Bioceutical $3.5m (usd) CanniMed Therapeutics $3.8m (usd) Namaste Technologies $2.5m (usd) Where is CanniMed on this list? And this is a 30-40$ stock. get real.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities